Smart pumps help keep blood sugar in a tighter range for type 1 diabetes
NCT ID NCT06834334
First seen Mar 27, 2026 · Last updated May 23, 2026 · Updated 10 times
Summary
This study looked at three different advanced hybrid closed-loop (AHCL) insulin pump systems in 189 adults with type 1 diabetes. The goal was to see which system helped keep blood sugar levels in a tight target range (70-140 mg/dL) more effectively. Participants had used their pump for at least three months, and the study measured how long their glucose stayed in that ideal range over 14 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Badajoz University Hospital
Badajoz, Badajoz, 06080, Spain
-
Ciudad Real General University Hospital
Ciudad Real, Ciudad Real, 13005, Spain
-
Hospital Universitario Mutua de Tarrasa
Terrassa, Barcelona, 08221, Spain
Conditions
Explore the condition pages connected to this study.